ARTICLE | Politics & Policy

NIAID funds development of new vaccine adjuvants

October 1, 2014 3:26 AM UTC

NIH's National Institute of Allergy and Infectious Diseases awarded five-year contracts to seven research institutions developing new vaccine adjuvants that boost responses by activating the adaptive immune system. The agency said total funding for all seven contracts could reach $70 million.

NIAID said the awardees will use computer models to screen molecules for adaptive immune responses, identify and structurally modify promising candidates, and test the optimized candidates in animal models. ...